Main description:

Antimicrobial resistance is a major global public health problem. This book focuses on the clinical implications of multi-drug resistant pathogens; tracking AMR and its evolutionary significance; antifungal resistance; and current and alternative treatment strategies for AMR, including antivirulent, antibiofilm and antimicrobial resistance breakers, repurposing of drugs, and probiotic therapy. Advances in antimicrobial stewardship, antibiotic policies from a global perspective and their impacts are also discussed. The book also explores the use of omics approaches to gain insights into antibacterial resistance, and includes chapters on the potential benefits of a 'One Health approach' describing the environmental and zoonotic sources of resistant genes and their effects on the global resistance pool.

Contents:

Implications of Multidrug resistant pathogens in clinical settings
Antimicrobial resistance: Microbial adaptation and evolution
Emerging microtechnologies and molecular tools for antimicrobial susceptibility testing and resistance detection
Current treatment regimen and control measures for multidrug resistant pathogens in clinical settings and future perspectives
Genomic tools to gain insights to the emergence of antibiotic resistant pathogens
Multidrug resistance in fungi
Advances of antimicrobial stewardship and its impact on antimicrobial resistance in middle income countries
Antimicrobial resistance genes: Transmission from environmental settings to humans
AMR: One Health approach
Antimicrobial resistance of zoonotic origin and its contribution towards resistance gene pool
Alternative strategies to tackle antimicrobial resistance
Repurposing of drugs, antimicrobial resistance breakers and combinatorial therapies